6 completed, 2 unknown, 1 recruiting. 9 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 6, Unknown 2, Recruiting 1 |
Follow Digoxin: new trials by email Literature Review of Digoxin trials Research Report on Digoxin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Digoxin Short Term Treatment Assessment Randomized Trial in AHF Digoxin, Placebo - Acute Heart Failure | Phase 3 | Completed | University of Monastir | 500 | 2023-05-01 | 2026-10-22 |
| Left Atrium Reservoir Function Modulation in Patients With Atrial Fibrillation: Digoxin Versus Beta Blocker Digoxin 0.25 mg, Bisoprolol - Atrial Fibrillation, Left Atrial Rhythm | Phase 3 | Unknown | University of Monastir | 30 | 2022-09-12 | 2022-09-16 |
| IvaBRAdine blocK of Funny Current for Heart Rate Control in permanEnt Atrial Fibrillation. (BRAKE-AF Study). Ivabradine, Digoxin - Atrial Fibrillation, Heart Diseases | Phase 3 | Completed | Adolfo Fontenla | 68 | 2018-10-19 | 2022-10-07 |
| Efficacy of Ivabradine in Patient With Both Persistent Atrial Fibrillation and Heart Failure With Reduce Ejection Fraction Ivabradine 5 mg [Corlanor], Digoxin 0.25 mg - Atrial Fibrillation, Ivabradine | Phase 3 | Unknown | Chun-Yao Huang | 100 | 2018-08-26 | 2020-03-13 |
| Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) AL3818, Dacarbazine, AL3818 or placebo - Alveolar Soft Part Sarcoma, Leiomyosarcoma | Phase 3 | Recruiting | Advenchen Laboratories, LLC | 325 | 2017-08-15 | 2026-02-25 |
| Prospective Randomized Clinical Trial of Fetal Atrial Flutter & Supraventricular Tachycardia Therapy (FAST RCT) Digoxin (monotherapy), Sotalol (monotherapy), Flecainide (monotherapy) - Fetal Atrial Flutter Without Hydrops, Fetal Supraventricular Tachycardia Without Hydrops | Phase 3 | Completed | Edgar Jaeggi | 105 | 2016-02-01 | 2024-05-22 |
| Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation Amiodarone, DC-cardioversion, Rate Control - Postoperative Atrial Fibrillation | Phase 3 | Completed | Icahn School of Medicine at Mount Sinai | 523 | 2014-05-01 | 2019-03-15 |
| Multicenter Study of Antiarrhythmic Medications for Treatment of Infants With Supraventricular Tachycardia Digoxin, Propranolol - Supraventricular Tachycardia | Phase 3 | Completed | University of British Columbia | 72 | 2006-10-01 | 2017-12-13 |
| Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) amiodarone, sotalol, propafenone - Arrhythmia, Atrial Fibrillation | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1995-03-01 | 2016-03-25 |
Atrial Fibrillation (5) · Arrhythmias, Cardiac (2) · Heart Diseases (2) · Atrial Flutter (1) · Cardiovascular Diseases (1) · Heart Failure (1) · Leiomyosarcoma (1) · Sarcoma (1) · Sarcoma, Alveolar Soft Part (1) · Sarcoma, Synovial (1) · Tachycardia, Supraventricular (1)
University of Monastir (2) · Adolfo Fontenla (1) · Advenchen Laboratories, LLC (1) · Chun-Yao Huang (1) · Edgar Jaeggi (1) · Icahn School of Medicine at Mount Sinai (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · University of British Columbia (1)
United States (4) · Canada (3) · Spain (2) · Tunisia (2) · United Kingdom (2) · Australia (1) · China (1) · Germany (1) · Italy (1) · Netherlands (1) · Taiwan (1)
Adolfo Fontenla, MD, PhD (1) · Edgar Jaeggi, MD (1) · H. Greene (1) · Nidhal Bouchahda, MD (1) · Nouira Semir, Professor (1) · Patrick T O'Gara, MD (1) · Richard Wiesel, MD (1) · Shubhayan Sanatani, MD (1)
PMID 22032709, PMID 22962431, PMID 27043047, PMID 28974568, PMID 29043263, PMID 31631048, PMID 39725795
2018 (1), U01HL088942 (1)